You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The agency said that an individual involved in a urine testing kickback had agreed to a settlement, while a defendant in a genetic testing fraud case plead guilty.
Michael and Regan Dube will pay a total of $9,015,046, plus interest as a result of their convictions. Regan Dube was previously sentenced in November.
The healthcare company and its subsidiary allegedly ordered residents of a residential treatment center to undergo unnecessary drug screenings multiple times a week.
Federal prosecutors alleged AutoGenomics paid nursing home patients to get tested in exchange for being referred for testing.
In a court complaint, the SEC alleges that from March to at least June, Decision Diagnostics falsely claimed it had developed a blood test for COVID-19.
The trio pleaded guilty of paying and receiving kickbacks for referrals of urine drug testing and receiving improper payments from Medicare.
Amid increasing spending on genetic testing, there are more opportunities for bad actors to implement interstate, fraudulent billing schemes, according to OIG.
Another owner of the lab also received kickbacks from third parties for referring individuals to those parties totaling $441,646.
The federal government alleged Phamatech paid a clinic to refer it drug testing business, violating the federal Anti-Kickback Statute and the False Claims Act.
Last month the agency said it had begun examining Medicare claims data to look for potential fraud in ordering of SARS-CoV-2 testing and related tests.